What are the challenges in activating the immune system against cancer?
Activating the immune system against cancer is fraught with challenges. Tumor heterogeneity, where different cells within the same tumor exhibit different antigens, complicates treatment. The immunosuppressive tumor microenvironment also poses a significant barrier. Additionally, there is a risk of autoimmunity, where the activated immune system might attack normal tissues.
